粘滑点眼薬の世界市場 (2022年～2030年)：市場規模 (APIタイプ・調剤区分・薬剤区分・流通チャネル別)・成長の潜在性・価格動向・競合市場シェア・予測

DED、緑内障、その他の眼科疾患の世界的な発生率の増加により、粘滑点眼薬の市場は2030年にかけて大幅に拡大すると予測されています。

2021年の世界保健機関の推計によると、世界で22億人以上が近視や遠視に悩まされています。

APIタイプ別で見ると、セルロース誘導体の部門が2030年には20%超のシェアを示すと予測されています。他の有効成分と比較して、セルロース誘導体は粘度が高く、眼球表面に長時間留まることができるため、セルロース誘導体は製造業者に特に好まれています。

当レポートでは、世界の粘滑点眼薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、技術・イノベーションの情勢、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 粘滑点眼薬産業の考察

• 産業の分類
• 産業情勢
• 産業への影響要因
  • 促進要因
  • 産業の潜在的リスク＆課題
• 成長性分析
• COVID-19：影響分析
• 産業エコシステム分析
• 疫学的分析
• パイプライン分析
• 技術・イノベーションの情勢
• 規制状況
• ポーターの分析
• 競合情勢
• PESTEL分析

第4章 粘滑点眼薬市場：APIタイプ別

• 主要動向
• セルロース誘導体
• デキストラン70
• ポリオール
• ポリマー
• その他

第5章 粘滑点眼薬市場：調剤区分別

• 主要動向
• 防腐剤ベース
• 防腐剤不使用

第6章 粘滑点眼薬市場：薬剤区分別

• 主要動向
• 店頭（OTC）
• 処方

第7章 粘滑点眼薬市場：流通チャネル別

• 主要動向
• 病院薬局
• 小売薬局
• オンライン薬局

第8章 粘滑点眼薬市場：地域別

• 主要動向
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第9章 企業プロファイル

• 競合ダッシュボード
• Johnson and Johnson Services, Inc.
• Alcon Inc.
• OASIS Medical
• Allergan（AbbVie Inc.）
• Prestige Consumer Healthcare Inc.
• Santen Pharmaceutical Co., Ltd.
• Bausch Health Companies Inc.
• Aurolab
• Otsuka Pharmaceutical Co.,Ltd.
• Sentiss Pharma Pvt. Ltd.
• Sun Pharmaceutical Industries Ltd.
• URSAPHARM Arzneimittel GmbH

Data Tables

• TABLE 1 Global demulcent eye drops market, 2017 - 2021 (USD Million)
• TABLE 2 Global demulcent eye drops market, 2022 - 2030 (USD Million)
• TABLE 3 Global demulcent eye drops market, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 4 Global demulcent eye drops market, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 5 Global demulcent eye drops market, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 6 Global demulcent eye drops market, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 7 Global demulcent eye drops market, by medication type, 2017 - 2021 (USD Million)
• TABLE 8 Global demulcent eye drops market, by medication type, 2022 - 2030 (USD Million)
• TABLE 9 Global demulcent eye drops market, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 10 Global demulcent eye drops market, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 11 Global demulcent eye drops market, by region, 2017 - 2021 (USD Million)
• TABLE 12 Global demulcent eye drops market, by region, 2022 - 2030 (USD Million)
• TABLE 13 Industry impact forces
• TABLE 14 Polyols market size, by region, 2017 - 2021 (USD Million)
• TABLE 15 Polyols market size, by region, 2022 - 2030 (USD Million)
• TABLE 16 Cellulose derivatives market size, by region, 2017 - 2021 (USD Million)
• TABLE 17 Cellulose derivatives market size, by region, 2022 - 2030 (USD Million)
• TABLE 18 Polymers market size, by region, 2017 - 2021 (USD Million)
• TABLE 19 Polymers market size, by region, 2022 - 2030 (USD Million)
• TABLE 20 Dextran 70 market size, by region, 2017 - 2021 (USD Million)
• TABLE 21 Dextran 70 market size, by region, 2022 - 2030 (USD Million)
• TABLE 22 Others market size, by region, 2017 - 2021 (USD Million)
• TABLE 23 Others market size, by region, 2022 - 2030 (USD Million)
• TABLE 24 Preservative based market size, by region, 2017 - 2021 (USD Million)
• TABLE 25 Preservative based market size, by region, 2022 - 2030 (USD Million)
• TABLE 26 Non-preservative based market size, by region, 2017 - 2021 (USD Million)
• TABLE 27 Non-preservative based market size, by region, 2022 - 2030 (USD Million)
• TABLE 28 Over-the-counter (OTC) market size, by region, 2017 - 2021 (USD Million)
• TABLE 29 Over-the-counter (OTC) market size, by region, 2022 - 2030 (USD Million)
• TABLE 30 Prescription market size, by region, 2017 - 2021 (USD Million)
• TABLE 31 Prescription market size, by region, 2022 - 2030 (USD Million)
• TABLE 32 Retail pharmacies market size, by region, 2017 - 2021 (USD Million)
• TABLE 33 Retail pharmacies market size, by region, 2022 - 2030 (USD Million)
• TABLE 34 Hospital pharmacies market size, by region, 2017 - 2021 (USD Million)
• TABLE 35 Hospital pharmacies market size, by region, 2022 - 2030 (USD Million)
• TABLE 36 Online pharmacies market size, by region, 2017 - 2021 (USD Million)
• TABLE 37 Online pharmacies market size, by region, 2022 - 2030 (USD Million)
• TABLE 38 North America demulcent eye drops Market size, by country, 2017 - 2021 (USD Million)
• TABLE 39 North America demulcent eye drops Market size, by country, 2022 - 2030 (USD Million)
• TABLE 40 North America demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 41 North America demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 42 North America demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 43 North America demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 44 North America Demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 45 North America Demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 46 North America demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 47 North America demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 48 U.S. demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 49 U.S. demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 50 U.S. demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 51 U.S. demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 52 U.S. demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 53 U.S. demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 54 U.S. demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 55 U.S. demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 56 Canada demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 57 Canada demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 58 Canada demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 59 Canada demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 60 Canada demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 61 Canada demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 62 Canada demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 63 Canada demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 64 Europe demulcent eye drops Market size, by country, 2017 - 2021 (USD Million)
• TABLE 65 Europe demulcent eye drops Market size, by country, 2022 - 2030 (USD Million)
• TABLE 66 Europe demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 67 Europe demulcent eye drops Market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 68 Europe demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 69 Europe demulcent eye drops Market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 70 Europe demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 71 Europe demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 72 Europe demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 73 Europe demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 74 Germany demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 75 Germany demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 76 Germany demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 77 Germany demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 78 Germany demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 79 Germany demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 80 Germany demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 81 Germany demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 82 UK demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 83 UK demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 84 UK demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 85 UK demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 86 UK demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 87 UK demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 88 UK demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 89 UK demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 90 France demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 91 France demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 92 France demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 93 France demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 94 France demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 95 France demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 96 France demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 97 France demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 98 Italy demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 99 Italy demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 100 Italy demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 101 Italy demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 102 Italy demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 103 Italy demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 104 Italy demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 105 Italy demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 106 Spain demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 107 Spain demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 108 Spain demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 109 Spain demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 110 Spain demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 111 Spain demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 112 Spain demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 113 Spain demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 114 Asia Pacific demulcent eye drops Market size, by country, 2017 - 2021 (USD Million)
• TABLE 115 Asia Pacific demulcent eye drops Market size, by country, 2022 - 2030 (USD Million)
• TABLE 116 Asia Pacific demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 117 Asia Pacific demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 118 Asia Pacific demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 119 Asia Pacific demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 120 Asia Pacific demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 121 Asia Pacific demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 122 Asia Pacific demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 123 Asia Pacific demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 124 India demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 125 India demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 126 India demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 127 India demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 128 India demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 129 India demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 130 India demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 131 India demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 132 China demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 133 China demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 134 China demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 135 China demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 136 China demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 137 China demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 138 China demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 139 China demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 140 Japan demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 141 Japan demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 142 Japan demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 143 Japan demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 144 Japan demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 145 Japan demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 146 Japan demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 147 Japan demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 148 Australia demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 149 Australia demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 150 Australia demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 151 Australia demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 152 Australia demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 153 Australia demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 154 Australia demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 155 Australia demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 156 South Korea demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 157 South Korea demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 158 South Korea demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 159 South Korea demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 160 South Korea demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 161 South Korea demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 162 South Korea demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 163 South Korea demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 164 Latin America demulcent eye drops Market size, by country, 2017 - 2021 (USD Million)
• TABLE 165 Latin America demulcent eye drops Market size, by country, 2022 - 2030 (USD Million)
• TABLE 166 Latin America demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 167 Latin America demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 168 Latin America demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 169 Latin America demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 170 Latin America demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 171 Latin America demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 172 Latin America demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 173 Latin America demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 174 Brazil demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 175 Brazil demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 176 Brazil demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 177 Brazil demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 178 Brazil demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 179 Brazil demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 180 Brazil demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 181 Brazil demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 182 Mexico demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 183 Mexico demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 184 Mexico demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 185 Mexico demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 186 Mexico demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 187 Mexico demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 188 Mexico demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 189 Mexico demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 190 MEA demulcent eye drops market size, by country, 2017 - 2021 (USD Million)
• TABLE 191 MEA demulcent eye drops market size, by country, 2022 - 2030 (USD Million)
• TABLE 192 MEA demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 193 MEA demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 194 MEA demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 195 MEA demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 196 MEA demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 197 MEA demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 198 MEA demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 199 MEA demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 200 South Africa demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 201 South Africa demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 202 South Africa demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 203 South Africa demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 204 South Africa demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 205 South Africa demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 206 South Africa demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 207 South Africa demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 208 Saudi Arabia demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 209 Saudi Arabia demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 210 Saudi Arabia demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 211 Saudi Arabia demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 212 Saudi Arabia demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 213 Saudi Arabia demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 214 Saudi Arabia demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 215 Saudi Arabia demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)
• TABLE 216 UAE demulcent eye drops market size, by active pharmaceutical ingredient, 2017 - 2021 (USD Million)
• TABLE 217 UAE demulcent eye drops market size, by active pharmaceutical ingredient, 2022 - 2030 (USD Million)
• TABLE 218 UAE demulcent eye drops market size, by drug formulation, 2017 - 2021 (USD Million)
• TABLE 219 UAE demulcent eye drops market size, by drug formulation, 2022 - 2030 (USD Million)
• TABLE 220 UAE demulcent eye drops market size, by medication type, 2017 - 2021 (USD Million)
• TABLE 221 UAE demulcent eye drops market size, by medication type, 2022 - 2030 (USD Million)
• TABLE 222 UAE demulcent eye drops market size, by distribution channel, 2017 - 2021 (USD Million)
• TABLE 223 UAE demulcent eye drops market size, by distribution channel, 2022 - 2030 (USD Million)

Charts & Figures

• FIG. 1 Demulcent eye drops industry 360 degree synopsis, 2017 - 2030
• FIG. 2 Industry segmentation
• FIG. 3 Global demulcent eye drops market, 2017 - 2030 (USD Million)
• FIG. 4 Growth potential analysis, by active pharmaceutical ingredient
• FIG. 5 Growth potential analysis, by drug formulation
• FIG. 6 Growth potential analysis, by medication type
• FIG. 7 Growth potential analysis, by distribution channel
• FIG. 8 Porter's analysis
• FIG. 9 PESTEL analysis
• FIG. 10 Key segment trends, by active pharmaceutical ingredient
• FIG. 11 Key segment trends, by drug formulation
• FIG. 12 Key segment trends, by medication type
• FIG. 13 Key segment trends, by distribution channel
• FIG. 14 Key regional trends
• FIG. 15 Competitive dashboard, 2021

The demulcent eye drops market is predicted to expand substantially through 2030, owing to the growing incidence of DED, glaucoma, and other eye illnesses across the globe. According to World Health Organization estimates of 2021, over 2.2 billion people worldwide suffer from near or distance vision ailment.

Notably, demulcents are mucoprotective substances that minimize irritation and inflammation of the mucous membrane and retain moisture to lubricate the surface of the eye. Inflowing investments by manufacturers and enterprises to enhance the technology to introduce novel OTC demulcent eye drops products will drive the industry growth. Citing an instance, after receiving the FDA clearance for the sale of OTC medications, in February 2021, Alcon, an eye care company, announced the availability of Pataday® Once Daily Relief Extra Strength eye drops at all retail pharmacies in the United States.

Based on type of active pharmaceutical ingredient, the cellulose derivatives segment is expected to occupy over 20% market share by the year 2030. Compared to other available ingredients, manufacturers highly prefer cellulose derivatives owing to their high viscosity and capacity to stay on the ocular surface for an extended period of time. The benefits API in demulcent eye drops to maintain eye moisture is promoting the segmental development.

As per drug formulation, the preservative-based segment is poised to gain traction in the coming years. The Food and Drug Administration mandates the preservatives to be added in multidose formulations to eliminate germs and fungus that might contaminate the liquid in the container over a period of time. The availability of demulcent eye drops with safer preservatives like Polyquad, SofZia, and Purite, which are gentler to the eyes and are available in multidose sterile packaging will boost the segment share.

According to research, prescription medication type segment is slated to generate moderate revenues for the demulcent eye drops industry over the forecast period, owing to the rapid progression of myopia among young children globally. As per the 2020 data by Centers for Disease Control and Prevention (CDC), around 6.8% children under the age of 18 years are diagnosed with eye conditions in the United States.

Speaking of distribution channel, online pharmacies are getting popular among the consumers because of 24x7 service availability and an endless supply of goods. Additionally, compared to local pharmacy stores, online pharmacies provide medicines at lower price and also offer a variety of discounts to promote sales. This, in tandem is estimated to boost the sales of demulcent eye drops through online platforms.

Regionally, LATAM demulcent eye drops market is expected to accumulate significant revenues and grow at over 4.5% CAGR through 2030, on account of huge population base in the region. Furthermore, the growing popularity of medical tourism, which has drawn vast number of people seeking diagnosis and treatment for eye ailments to the LATAM countries will bolster the product demand.

Businesses involved in the production of demulcent eye drops are putting in tactical efforts, including collaborations and product portfolio expansions, to increase their market share. For instance, in May 2022, Alcon announced its plan to acquire EYSUVIS (corticosteroid indicated for short-term treatment of DED) from Kala Pharmaceuticals Inc., a clinical-stage biopharma company. The acquisition will broaden the company's portfolio of ophthalmic eye drops.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Base estimates and working
  • 1.2.1 North America
  • 1.2.2 Europe
  • 1.2.3 Asia Pacific
  • 1.2.4 Latin America
  • 1.2.5 MEA
• 1.3 Forecast parameters
• 1.4 Data validation
• 1.5 Data sources
  • 1.5.1 Secondary
    • 1.5.1.1 Paid sources
    • 1.5.1.2 Unpaid sources
  • 1.5.2 Primary

Chapter 2 Executive Summary

• 2.1 Demulcent eye drops industry 360 degree synopsis, 2017 - 2030
  • 2.1.1 Business trends
  • 2.1.2 Active pharmaceutical ingredient type trends
  • 2.1.3 Drug formulation trends
  • 2.1.4 Medication type trends
  • 2.1.5 Distribution channel trends
  • 2.1.6 Regional trends

Chapter 3 Demulcent Eye Drops Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2017 - 2030
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Surge in the prevalence of eye diseases
    • 3.3.1.2 Innovative drug formulation launches due to advancements in technology
    • 3.3.1.3 Growing awareness regarding eye diseases among population base
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 Side-effects associated with demulcent eye drops solutions
    • 3.3.2.2 Numerous challenges encountered during treatment of various eye diseases
• 3.4 Growth potential analysis
  • 3.4.1 By active pharmaceutical ingredient type
  • 3.4.2 By drug formulation
  • 3.4.3 By medication type
  • 3.4.4 By distribution channel
• 3.5 COVID- 19 impact analysis
• 3.6 Industry ecosystem analysis
  • 3.6.1 Raw materials and component suppliers
  • 3.6.2 Manufacturers
  • 3.6.3 Distribution channel analysis
  • 3.6.4 End users
  • 3.6.5 Vendor matrix
• 3.7 Epidemiological analysis
• 3.8 Pipeline analysis
• 3.9 Technology and innovation landscape, 2021
• 3.10 Regulatory landscape
  • 3.10.1 U.S.
  • 3.10.2 Europe
  • 3.10.3 Asia Pacific
• 3.11 Porter's analysis
  • 3.11.1 Bargaining power of suppliers
  • 3.11.2 Bargaining power of buyers
  • 3.11.3 Threat of new entrants
  • 3.11.4 Threat of substitutes
  • 3.11.5 Industry rivalry
• 3.12 Competitive landscape, 2021
  • 3.12.1 Alcon Inc.
  • 3.12.2 Bausch Health Companies Inc.
  • 3.12.3 Johnson and Johnson Services, Inc.
  • 3.12.4 Company matrix analysis, 2021
• 3.13 PESTEL analysis

Chapter 4 Demulcent Eye Drops Market, By Active Pharmaceutical Ingredient Type

• 4.1 Key segment trends
• 4.2 Cellulose Derivatives
  • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
• 4.3 Dextran 70
  • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
• 4.4 Polyols
  • 4.4.1 Market size, by region, 2017 - 2030 (USD Million)
• 4.5 Polymers
  • 4.5.1 Market size, by region, 2017 - 2030 (USD Million)
• 4.6 Others
  • 4.6.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Demulcent Eye Drops Market, By Drug Formulation

• 5.1 Key segment trends
• 5.2 Preservative Based
  • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
• 5.3 Non-Preservative Based
  • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Demulcent Eye Drops Market, By Medication Type

• 6.1 Key segment trends
• 6.2 Over-the-counter (OTC)
  • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
• 6.3 Prescription
  • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Demulcent Eye Drops Market, By Distribution Channel

• 7.1 Key segment trends
• 7.2 Hospital Pharmacies
  • 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
• 7.3 Retail Pharmacies
  • 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
• 7.4 Online Pharmacies
  • 7.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 8 Demulcent Eye Drops Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
  • 8.2.2 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
  • 8.2.3 Market size, by drug formulation, 2017 - 2030 (USD Million)
  • 8.2.4 Market size, by medication type, 2017 - 2030 (USD Million)
  • 8.2.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.2.6 U.S.
    • 8.2.6.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.2.6.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.2.6.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.2.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.2.7 Canada
    • 8.2.7.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.2.7.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.2.7.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.2.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
• 8.3 Europe
  • 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
  • 8.3.2 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
  • 8.3.3 Market size, by drug formulation, 2017 - 2030 (USD Million)
  • 8.3.4 Market size, by medication type, 2017 - 2030 (USD Million)
  • 8.3.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.3.6 Germany
    • 8.3.6.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.3.6.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.3.6.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.3.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.3.7 UK
    • 8.3.7.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.3.7.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.3.7.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.3.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.3.8 France
    • 8.3.8.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.3.8.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.3.8.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.3.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.3.9 Spain
    • 8.3.9.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.3.9.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.3.9.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.3.9.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.3.10 Italy
    • 8.3.10.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.3.10.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.3.10.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.3.10.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
  • 8.4.2 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
  • 8.4.3 Market size, by drug formulation, 2017 - 2030 (USD Million)
  • 8.4.4 Market size, by medication type, 2017 - 2030 (USD Million)
  • 8.4.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.4.6 China
    • 8.4.6.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.4.6.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.4.6.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.4.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.4.7 Japan
    • 8.4.7.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.4.7.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.4.7.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.4.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.4.8 India
    • 8.4.8.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.4.8.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.4.8.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.4.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.4.9 Australia
    • 8.4.9.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.4.9.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.4.9.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.4.9.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.4.10 South Korea
    • 8.4.10.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.4.10.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.4.10.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.4.10.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
  • 8.5.2 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
  • 8.5.3 Market size, by drug formulation, 2017 - 2030 (USD Million)
  • 8.5.4 Market size, by medication type, 2017 - 2030 (USD Million)
  • 8.5.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.5.6 Brazil
    • 8.5.6.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.5.6.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.5.6.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.5.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.5.7 Mexico
    • 8.5.7.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.5.7.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.5.7.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.5.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
• 8.6 Middle East & Africa
  • 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
  • 8.6.2 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
  • 8.6.3 Market size, by drug formulation, 2017 - 2030 (USD Million)
  • 8.6.4 Market size, by medication type, 2017 - 2030 (USD Million)
  • 8.6.5 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.6.6 Saudi Arabia
    • 8.6.6.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.6.6.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.6.6.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.6.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.6.7 South Africa
    • 8.6.7.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.6.7.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.6.7.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.6.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 8.6.8 UAE
    • 8.6.8.1 Market size, by active pharmaceutical ingredient type, 2017 - 2030 (USD Million)
    • 8.6.8.2 Market size, by drug formulation, 2017 - 2030 (USD Million)
    • 8.6.8.3 Market size, by medication type, 2017 - 2030 (USD Million)
    • 8.6.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)

Chapter 9 Company Profiles

• 9.1 Competitive dashboard, 2021
• 9.2 Johnson and Johnson Services, Inc.
  • 9.2.1 Business overview
  • 9.2.2 Financial data
  • 9.2.3 Drug formulation landscape
  • 9.2.4 Strategic outlook
  • 9.2.5 SWOT analysis
• 9.3 Alcon Inc.
  • 9.3.1 Business overview
  • 9.3.2 Financial data
  • 9.3.3 Drug formulation landscape
  • 9.3.4 Strategic outlook
  • 9.3.5 SWOT analysis
• 9.4 OASIS Medical
  • 9.4.1 Business overview
  • 9.4.2 Financial data
  • 9.4.3 Drug formulation landscape
  • 9.4.4 Strategic outlook
  • 9.4.5 SWOT analysis
• 9.5 Allergan (AbbVie Inc.)
  • 9.5.1 Business overview
  • 9.5.2 Financial data
  • 9.5.3 Drug formulation landscape
  • 9.5.4 Strategic outlook
  • 9.5.5 SWOT analysis
• 9.6 Prestige Consumer Healthcare Inc.
  • 9.6.1 Business overview
  • 9.6.2 Financial data
  • 9.6.3 Drug formulation landscape
  • 9.6.4 Strategic outlook
  • 9.6.5 SWOT analysis
• 9.7 Santen Pharmaceutical Co., Ltd.
  • 9.7.1 Business overview
  • 9.7.2 Financial data
  • 9.7.3 Drug formulation landscape
  • 9.7.4 Strategic outlook
  • 9.7.5 SWOT analysis
• 9.8 Bausch Health Companies Inc.
  • 9.8.1 Business overview
  • 9.8.2 Financial data
  • 9.8.3 Drug formulation landscape
  • 9.8.4 Strategic outlook
  • 9.8.5 SWOT analysis
• 9.9 Aurolab
  • 9.9.1 Business overview
  • 9.9.2 Financial data
  • 9.9.3 Drug formulation landscape
  • 9.9.4 Strategic outlook
  • 9.9.5 SWOT analysis
• 9.10 Otsuka Pharmaceutical Co.,Ltd.
  • 9.10.1 Business overview
  • 9.10.2 Financial data
  • 9.10.3 Drug formulation landscape
  • 9.10.4 Strategic outlook
  • 9.10.5 SWOT analysis
• 9.11 Sentiss Pharma Pvt. Ltd.
  • 9.11.1 Business overview
  • 9.11.2 Financial data
  • 9.11.3 Drug formulation landscape
  • 9.11.4 Strategic outlook
  • 9.11.5 SWOT analysis
• 9.12 Sun Pharmaceutical Industries Ltd.
  • 9.12.1 Business overview
  • 9.12.2 Financial data
  • 9.12.3 Drug formulation landscape
  • 9.12.4 Strategic outlook
  • 9.12.5 SWOT analysis
• 9.13 URSAPHARM Arzneimittel GmbH
  • 9.13.1 Business overview
  • 9.13.2 Financial data
  • 9.13.3 Drug formulation landscape
  • 9.13.4 Strategic outlook
  • 9.13.5 SWOT analysis